FOR US AUDIENCES ONLY
Otezla® (apremilast) is a prescription medicine used to treat adult patients with:
Otezla is a pill that can help you achieve clearer skin
Otezla is the only pill of its kind approved by the FDA to treat all severities of plaque psoriasis—mild, moderate, and severe.
75% clearer skin is achievable after just 4 months, with reduced redness, thickness, and scaliness of plaques in moderate to severe plaque psoriasis SEE RESULTS
Otezla is proven to help get clearer skin on your scalp after just 4 months in moderate to severe plaque psoriasis
SEE SCALP DATA
Not an injection or cream—Otezla is a pill that treats plaque psoriasis differently
Otezla works to reduce PDE4 activity—though the exact way in which Otezla helps improve symptoms isn't completely understood, it's thought to help reduce inflammation
for adults with moderate to severe psoriasis starting a treatment that works inside the body*
*Based on IQVIA licensed data: Jan 2018 — June 2021 Longitudinal Prescription (LRx) Data and Medical Claims (Dx) Data, reflecting estimates of real-world activity. Study information maintained by Amgen. LRx Data covers retail, traditional/specialty mail order, and long-term claims. Dx data captures US physicians. Patient classified as systemic-naïve if not previously on systemic therapy for the past 12 months, had any claim for a branded systemic, and had at least one psoriasis diagnosis.
“The best part of Otezla is that it works for me.”
-Elicia, Actual Otezla patient
Jennifer's plaque psoriasis symptoms made her self-conscious. With Otezla, she's living differently.
*Certain restrictions apply.
Otezla® (apremilast) is a prescription medicine used to treat adult patients with:
You must not take Otezla if you are allergic to apremilast or to any of the ingredients in Otezla.
Otezla can cause allergic reactions, sometimes severe. Stop using Otezla and call your healthcare provider or seek emergency help right away if you develop any of the following symptoms of a serious allergic reaction: trouble breathing or swallowing, raised bumps (hives), rash or itching, swelling of the face, lips, tongue, throat or arms.
Otezla can cause severe diarrhea, nausea, and vomiting, especially within the first few weeks of treatment. Use in elderly patients and the use of certain medications with Otezla appears to increase the risk of complications from having severe diarrhea, nausea, or vomiting. Tell your doctor if any of these conditions occur.
Otezla is associated with an increase in depression. In clinical studies, some patients reported depression, or suicidal behavior while taking Otezla. Some patients stopped taking Otezla due to depression. Before starting Otezla, tell your doctor if you have had feelings of depression, or suicidal thoughts or behavior. Be sure to tell your doctor if any of these symptoms or other mood changes develop or worsen during treatment with Otezla.
Some patients taking Otezla lost body weight. Your doctor should monitor your weight regularly. If unexplained or significant weight loss occurs, your doctor will decide if you should continue taking Otezla.
Some medicines may make Otezla less effective and should not be taken with Otezla. Tell your doctor about all the medicines you take, including prescription and nonprescription medicines.
The most common side effects of Otezla include diarrhea, nausea, upper respiratory tract infection, tension headache, and headache. These are not all the possible side effects with Otezla. Ask your doctor about other potential side effects. Tell your doctor about any side effect that bothers you or does not go away.
Tell your doctor if you are pregnant, planning to become pregnant or planning to breastfeed.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-332-1088.
Please click here for the Full Prescribing Information for Otezla.
You must not take Otezla if you are allergic to apremilast or to any of the ingredients in Otezla.
Otezla can cause severe diarrhea, nausea, and vomiting, especially within the first few weeks of treatment. Use in elderly patients and the use of certain medications with Otezla appears to increase the risk of complications from having severe diarrhea, nausea, or vomiting. Tell your doctor if any of these conditions occur.
